TB Alliance Case Study on Expanding Access to Life-Saving Tuberculosis Treatments Published by INSEAD
MBA students tackle one of global health’s toughest challenges – how to reduce drug rollout…
Elizabeth Glaser Pediatric AIDS Foundation (EGPAF): Advancing Child Health, TB/HIV Integration, and Innovation in the Global TB Response
The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is a valued member of TB Alliance’s Global…
Academic Study Finds TB Alliance’s Access Approach Successfully Accelerated Uptake of New TB Treatments
Findings underscore critical role of product development partnerships in delivering both innovation and access GENEVA…
TB Alliance Case Study on Expanding Access to Life-Saving Tuberculosis Treatments Published by INSEAD
MBA students tackle one of global health’s toughest challenges – how to reduce drug rollout…
Academic Study Finds TB Alliance’s Access Approach Successfully Accelerated Uptake of New TB Treatments
Findings underscore critical role of product development partnerships in delivering both innovation and access GENEVA…
New Report: LIFT-TB Helped Cut Time to Global Uptake of Improved Drug-Resistant TB Treatments from Nearly a Decade to Three Years
Country-led evidence and implementation support enabled faster adoption of shorter, more effective regimens worldwide SEOUL…
TB Alliance Announces New Collaboration with Novartis to Advance the Research and Development of Telacebec for Leprosy
New collaboration aims to advance innovation for a neglected and stigmatizing disease affecting hundreds of…
Promising New Data on Pediatric Use of Pretomanid in Children with Drug-Resistant Tuberculosis Presented at 2025 Union Conference
Positive results mark an important step forward in efforts to develop effective treatments for children…
Phase 2 Clinical Trial Results Show Potential to Shorten TB Treatment Time
Thuto Pulane, a TB survivor and participant in the NC-009 trial, at a follow-up appointment…
TB Alliance Case Study on Expanding Access to Life-Saving Tuberculosis Treatments Published by INSEAD
MBA students tackle one of global health’s toughest challenges – how to reduce drug rollout…
Academic Study Finds TB Alliance’s Access Approach Successfully Accelerated Uptake of New TB Treatments
Findings underscore critical role of product development partnerships in delivering both innovation and access GENEVA…
New Report: LIFT-TB Helped Cut Time to Global Uptake of Improved Drug-Resistant TB Treatments from Nearly a Decade to Three Years
Country-led evidence and implementation support enabled faster adoption of shorter, more effective regimens worldwide SEOUL…